• / Free eNewsletters & Magazine
  • / My Account
Home>Novartis Gets EU Approval For Glaucoma Drug

Novartis Gets EU Approval For Glaucoma Drug

3party Content

Mon, 28 Jul 2014

ZURICH--Novartis AG (NVS) said Monday the European Commission had approved its Simbrinza eye drops for use in patients with the sight-threatening disease glaucoma. Simbrinza, made by the Basel-based pharmaceutical giant's Alcon eyecare unit, doesn't contain beta blockers, a class of drugs that is
Upcoming Events

©2014 Morningstar Advisor. All right reserved.